Neuroscience

Targeting tau, the other protein behind Alzheimer's disease

In November, researchers reported the drug lecanemab slowed the progression of Alzheimer's disease. The effect was modest, but it has generated tremendous excitement because it was the first time a drug had been shown to ...

Diseases, Conditions, Syndromes

After three years, COVID 'here to stay'

While the World Health Organization hopes COVID-19 will soon no longer be considered a public health emergency, it has warned the virus itself is here to stay.

page 8 from 40